Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).

Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Lung Cancer Causes

Lung Cancer Symptoms

Lung Cancer Diagnosis

Epidemiology of Lung Cancer

Lung Cancer Treatments

Lung Cancer Research

Lung Cancer Questions

How to Prevent Lung Cancer

Lung Cancer Genetics

Lung Cancer Pathogenesis

What Causes Lung Cancer in Non-Smokers?

See more featured articles »

Lung Cancer: Radiotherapy and Chemotherapy

Types of Lung Cancer Surgery

Lymph Nodes in Lung Cancer

Pulmonary Resection in Lung Cancer

Palliative and End-of-Life Care in Lung Cancer

Secondary Lung Cancer

Carcinogens in Cigarette Smoke

Lung Cancer Screening Procedure

Lung Cancer and Electrolyte Imbalances

Lung Cancer Risk Factors

Everything You Need to Know About Giving Up Cigarettes

Immunotherapy: The Future of Lung Cancer Treatment?

Lung Plethysmography Procedure

Pulmonary Transplant (Lung Transplant)

What are the Survival Rates for Lung Cancer?

Exploring Diversity in Lung Cancer: Impact on Incidence, Prognosis, and Treatment Strategies

Lung Cancer in Women: Understanding the Increasing Risk

Latest Lung Cancer News and Research

Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 225Ac-SSO110 (satoreotide) for the treatment of patients with Small Cell Lung Cancer (SCLC).

10 Feb 2025

Researchers discover strategy to slow brain metastases growth in melanoma

Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University (UMH) in Elche, have identified a strategy to slow their progression, which could improve the response to current treatments.

7 Feb 2025

Cancer incidence and deaths still higher in Appalachia despite progress

Fewer people than before are being diagnosed with and dying from cancer in Appalachia, but cancer incidence and death rates remain substantially higher, especially in certain areas of Central Appalachia, compared to elsewhere in the U.S.

7 Feb 2025

Mayo Clinic develops AI tool to visualize complex biological data

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images.

6 Feb 2025

RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report."

6 Feb 2025

Microbes in your gut could determine cancer treatment outcomes

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment, with specific bacterial strains enhancing or inhibiting anti-tumor immunity.

4 Feb 2025

Researchers develop model to identify tumor-fighting immune cells in lung cancer patients

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

3 Feb 2025

Study could help predict treatment response for KRASG12C-mutant non-small cell lung cancer

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies.

31 Jan 2025

New AI approach enhances personalized medicine in cancer care

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease.

30 Jan 2025

Chemotherapy linked to persistent nerve pain in 4 in 10 cancer patients

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the available evidence, published in the open access journal Regional Anesthesia & Pain Medicine.

29 Jan 2025

An Arm and a Leg: The ‘Shkreli Awards’ — for dysfunction and profiteering in health care

Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of "profiteering and dysfunction" in health care and "honors" the winners.

27 Jan 2025

Ross procedure offers durable results in young patients

Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the majority without the need for additional surgery two decades later.

27 Jan 2025

Mechanical aortic valves showed improved long-term survival in patients aged 60 and younger

A late-breaking study presented today at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for patients aged 60 and younger compared to bioprosthetic valves. The study, leveraging data from the STS Adult Cardiac Surgery Database (ACSD), offers the most comprehensive analysis to date of prosthetic valve outcomes, encompassing over 100,000 patients.

26 Jan 2025

Real-world data reveals survival benefits of anatomic resections for early-stage lung cancer

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term survival compared to wedge resection for patients with early-stage non-small cell lung cancer (NSCLC).

26 Jan 2025

Surgeon preferences may explain differences in CABG survival rates

In patients undergoing coronary artery bypass grafting (CABG), a novel analysis evaluating surgeon preference for multi- versus single-arterial grafting may help explain the differing results between prior retrospective analyses and randomized controlled trials regarding long-term survival.

25 Jan 2025